Loading
companiesCompany
Arog Pharmaceuticals
Arog is a private Dallas biotech developing crenolanib, a FLT3 and PDGFR kinase inhibitor, through phase 3 trials in FLT3-mutant acute myeloid leukaemia and gastrointestinal stromal tumours.
Also called: Arog Pharmaceuticals, Inc.AROG
Overview
Arog Pharmaceuticals, based in Dallas, Texas, licensed crenolanib from Pfizer and has taken it into phase 3 trials in newly diagnosed and relapsed FLT3-mutated acute myeloid leukaemia and in PDGFRA D842V-mutant gastrointestinal stromal tumours, all registered on ClinicalTrials.gov under Arog as lead sponsor.
Similar pages
- CompanyCyclacel Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Acute myeloid leukaemia, Small-molecule kinase inhibitors.
- CompanyVion Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Acute myeloid leukaemia.
- CompanyJW Pharmaceutical
Shares Pivotal (registrational) trial, Clinical trial, Acute myeloid leukaemia.
- CompanySunesis Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Acute myeloid leukaemia.
- CompanyDenovo Biopharma
Shares Pivotal (registrational) trial, Clinical trial, Small-molecule kinase inhibitors.
- CompanyPregLem
- CompanyDelta-Fly Pharma
Shares Pivotal (registrational) trial, Clinical trial, Acute myeloid leukaemia.
- CompanyAgennix